“Triple Threat-Triple Benefit: The Rise of GLP1-GCG-FGF21 Tritagonists in Tomorrow’s Metabolic Medicine ”, d, vol. 3, no. 3, pp. 43–48, Dec. 2025, Accessed: Feb. 27, 2026. [Online]. Available: https://www.thediabzen.com/index.php/d/article/view/19